Cefpodoxime Proxetil Suppliers & Bulk Manufacturers

Available Forms: Tablets & oral suspension

Available Strengths: Tab: 100 mg. 200 mg, Susp: 50 mg/5 mL, 100 mg/5 mL

Reference Brands: Sefpotec®(EU); Vantin®(US- Dis.cntd but generics avialble)

Category: Respiratory Disorder

Cefpodoxime Proxetil is an oral cephalosporin antibiotic for respiratory, skin, and urinary infections. Available in the US and EU as tablets (100 mg, 200 mg) and suspensions (40–100 mg/5 mL), it’s marketed under brands like Sefpotec®, Foxero®, and generics—ideal for global B2B and pharma exports. Cefpodoxime Proxetil is available in Tablets & oral suspension and strengths such as Tab: 100 mg. 200 mg, Susp: 50 mg/5 mL, 100 mg/5 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Cefpodoxime Proxetil is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Cefpodoxime Proxetil can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Cefpodoxime Proxetil is a third-generation oral cephalosporin antibiotic widely used to treat respiratory tract infections, skin infections, and urinary tract infections. Available in both the US and EU, it comes in tablet strengths of 100 mg and 200 mg, and oral suspensions such as 50 mg/5 mL, 100 mg/5 mL, and 40 mg/5 mL. Though the brand Vantin® is discontinued in the US, numerous generics are available. In the EU, brands like Sefpotec® and Foxero® are common. Its broad-spectrum efficacy and oral convenience make it a top choice for B2B, PCD, and international pharmaceutical trade.